Shares of Open Orphan Plc (LON:ORPH – Get Free Report) traded up 5.3% during trading on Tuesday . The company traded as high as GBX 10.38 ($0.13) and last traded at GBX 10 ($0.13). 652,639 shares changed hands during mid-day trading, a decline of 58% from the average session volume of 1,559,247 shares. The stock had previously closed at GBX 9.50 ($0.12).
Open Orphan Price Performance
The company has a current ratio of 1.19, a quick ratio of 1.16 and a debt-to-equity ratio of 10.88. The company has a market cap of £67.09 million and a price-to-earnings ratio of -25.30. The company has a fifty day moving average price of GBX 10 and a two-hundred day moving average price of GBX 10.
About Open Orphan
Open Orphan Plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Further Reading
- Five stocks we like better than Open Orphan
- How Investors Can Find the Best Cheap Dividend Stocks
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- Insider Trades May Not Tell You What You Think
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- What is a Bond Market Holiday? How to Invest and Trade
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Open Orphan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Open Orphan and related companies with MarketBeat.com's FREE daily email newsletter.
